Isotretinoin for the treatment of sebaceous hyperplasia.
Two cases of diffuse multiple lesions of sebaceous hyperplasia of the face are reported. The results of both medical and surgical therapies had been unsatisfactory. The patients were treated with low dose systemic isotretinoin (13-cis-retinoic acid) which resulted in complete clearing in one case and substantial clearing in the second. We suggest that in those patients cosmetically bothered by diffuse multiple lesions of sebaceous hyperplasia, for which other therapies are unsuccessful or unamenable to the patient, isotretinoin offers a safe, rational therapeutic option.
D000368:Aged; D005148:Facial Dermatoses / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D006965:Hyperplasia; D015474:Isotretinoin; D008297:Male; D008875:Middle Aged; D012627:Sebaceous Glands / Q000473:pathology*; D012871:Skin Diseases / Q000188:drug therapy / Q000473:pathology; D014212:Tretinoin / Q000627:therapeutic use*
D014212:Tretinoin; D015474:Isotretinoin